Published in Am J Trop Med Hyg on November 01, 1990
Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood. J Clin Microbiol (1991) 2.82
Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil. Malar J (2007) 1.76
Genetic diversity of Plasmodium vivax in Kolkata, India. Malar J (2006) 1.49
Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens. J Clin Microbiol (1992) 1.33
Differential susceptibilities of Anopheles albimanus and Anopheles pseudopunctipennis to infections with coindigenous Plasmodium vivax variants VK210 and VK247 in southern Mexico. Infect Immun (1999) 1.29
Research priorities for the development and implementation of serological tools for malaria surveillance. F1000Prime Rep (2014) 0.94
Development of a Plasmodium berghei transgenic parasite expressing the full-length Plasmodium vivax circumsporozoite VK247 protein for testing vaccine efficacy in a murine model. Malar J (2016) 0.76
Multi-epitope chimeric antigen used as a serological marker to estimate Plasmodium falciparum transmission intensity in the border area of China-Myanmar. Infect Dis Poverty (2016) 0.75
What Is Known about the Immune Response Induced by Plasmodium vivax Malaria Vaccine Candidates? Front Immunol (2017) 0.75
Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei. Nature (1967) 6.08
Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J Exp Med (1980) 4.81
TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites. Cell (1997) 4.65
Genetic selection of a Plasmodium-refractory strain of the malaria vector Anopheles gambiae. Science (1986) 4.40
Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature (1989) 4.08
The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome. Proc Natl Acad Sci U S A (1998) 3.93
Migration of Plasmodium sporozoites through cells before infection. Science (2001) 3.89
Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science (1980) 3.71
Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science (1986) 3.33
Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med (1982) 3.26
Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science (1985) 3.24
Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet (1979) 3.22
Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J Exp Med (1983) 3.07
Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol (1999) 3.01
Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria. Science (1979) 2.91
Experimental mosquito-transmission of Plasmodium knowlesi to man and monkey. Am J Trop Med Hyg (1968) 2.89
Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17beta throughout the 4-day estrous cycle of the rat. Endocrinology (1974) 2.87
The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell (1992) 2.78
Monoclonal antibodies to circumsporozoite proteins identify the species of malaria parasite in infected mosquitoes. Nature (1982) 2.76
CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int Immunol (1991) 2.67
Population dynamics of untreated Plasmodium falciparum malaria within the adult human host during the expansion phase of the infection. Parasitology (2002) 2.67
Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol Res (1994) 2.65
Rationale for the development of an engineered sporozoite malaria vaccine. Adv Immunol (1989) 2.64
Structure of the plasmodium knowlesi gene coding for the circumsporozoite protein. Cell (1983) 2.60
Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes. Nature (1997) 2.49
DNA cloning of Plasmodium falciparum circumsporozoite gene: amino acid sequence of repetitive epitope. Science (1984) 2.47
Circumsporozoite proteins of malaria parasites. Cell (1985) 2.45
Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci U S A (1993) 2.44
Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope. Science (1985) 2.41
Research toward malaria vaccines. Science (1986) 2.40
The indirect fluorescent antibody test for malaria. Am J Trop Med Hyg (1972) 2.37
Identification of Plasmodium vivax-like human malaria parasite. Lancet (1993) 2.37
Further studies on the Plasmodium berghei-Anopheles stephensi--rodent system of mammalian malaria. J Parasitol (1968) 2.32
A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature (1988) 2.26
Sensitive detection of DNA polymorphisms by the serial invasive signal amplification reaction. Proc Natl Acad Sci U S A (2000) 2.21
Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J Immunol (1987) 2.19
Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum. Nature (1986) 2.19
Inhibition of entry of Plasmodium falciparum and P. vivax sporozoites into cultured cells; an in vitro assay of protective antibodies. J Immunol (1984) 2.18
Ubiquity of the repetitive epitope of the CS protein in different isolates of human malaria parasites. J Immunol (1985) 2.09
Increased nonspecific resstance to malaria produced by administration of killed Corynebacterium parvum. Exp Parasitol (1967) 2.06
Anophelines in the state of Acre, Brazil, infected with Plasmodium falciparum, P. vivax, the variant P. vivax VK247 and P. malariae. Trans R Soc Trop Med Hyg (1993) 2.03
Biosynthesis of Pb44, the protective antigen of sporozoites of Plasmodium berghei. J Exp Med (1981) 2.02
Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes. Parasitology (1999) 2.02
Antibody-induced ultrastructural changes of malarial sporozoites. J Immunol (1976) 1.97
Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis (1999) 1.96
Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J Infect Dis (2001) 1.94
Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull World Health Organ (1979) 1.92
Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi. Nature (1983) 1.90
Influenza and vaccinia viruses expressing malaria CD8+ T and B cell epitopes. Comparison of their immunogenicity and capacity to induce protective immunity. J Immunol (1994) 1.90
Specificity of protective immunity produced by x-irradiated Plasmodium berghei sporozoites. Nature (1969) 1.89
Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am J Trop Med Hyg (1982) 1.85
Induction of protective immunity against experimental infection with malaria using synthetic peptides. Nature (1987) 1.85
Monoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesi. Proc Natl Acad Sci U S A (1982) 1.82
Genesis, sequestration and survival of Plasmodium falciparum gametocytes: parameter estimates from fitting a model to malariatherapy data. Trans R Soc Trop Med Hyg (2001) 1.75
Structural and functional properties of region II-plus of the malaria circumsporozoite protein. J Exp Med (1994) 1.75
Evaluation of single nucleotide polymorphism typing with invader on PCR amplicons and its automation. Genome Res (2000) 1.71
Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. Proc Natl Acad Sci U S A (1994) 1.68
Immune phagocytosis in murine malaria. J Exp Med (1979) 1.66
Malaria sporozoite penetration. A new approach by double staining. J Immunol Methods (1988) 1.65
T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu Rev Immunol (1993) 1.64
Studies on the transmission of simian malarias. II. Transmission of the H strain of Plasmodium knowlesi by Anopheles balabacensis balabacensis. J Parasitol (1967) 1.63
Antibodies to the protective antigen of Plasmodium berghei sporozoites prevent entry into cultured cells. J Immunol (1982) 1.63
The circumsporozoite gene of the Plasmodium cynomolgi complex. Cell (1987) 1.61
Identification of malaria-infected mosquitoes by a two-site enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1984) 1.60
Geographic subdivision of the range of the malaria parasite Plasmodium vivax. Emerg Infect Dis (2001) 1.59
Plasmodium malariae blood-stage dynamics. J Parasitol (2001) 1.59
Synthetic peptide vaccine confers protection against murine malaria. J Exp Med (1987) 1.58
The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J Exp Med (1992) 1.56
Phylogenetic relationship among the malaria parasites based on small subunit rRNA gene sequences: monophyletic nature of the human malaria parasite, Plasmodium falciparum. Mol Phylogenet Evol (1996) 1.56
Plasmodium falciparum parasitaemia described by a new mathematical model. Parasitology (2001) 1.55
Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes. Infect Immun (2000) 1.54
Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proc Natl Acad Sci U S A (2001) 1.54
CD4+ cytolytic T cell clone confers protection against murine malaria. J Exp Med (1990) 1.51
Identification of Plasmodium vivax sporozoites in mosquitoes using an enzyme-linked immunosorbent assay. Am J Trop Med Hyg (1985) 1.50
Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J Exp Med (1990) 1.46
Sporozoites of mammalian malaria: attachment to, interiorization and fate within macrophages. J Protozool (1980) 1.46
Fluorescent antibody studies in human malaria. IV. Cross-reactions between human and simian malaria. Am J Trop Med Hyg (1966) 1.46
Species-specific 18S rRNA gene amplification for the detection of P. falciparum and P. vivax malaria parasites. Mol Cell Probes (1995) 1.46
The protective antigen of malarial sporozoites (Plasmodium berghei) is a differentiation antigen. J Immunol (1981) 1.45
Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis. Clin Exp Immunol (1979) 1.44
Exogenous interferon protects mice against Plasmodium berghei malaria. Nature (1970) 1.43
Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science (1991) 1.43
Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus. Science (1984) 1.42
Polymerase chain reaction and a liquid-phase, nonisotopic hybridization for species-specific and sensitive detection of malaria infection. Am J Trop Med Hyg (1995) 1.39
Characterization of in vivo primary and secondary CD8+ T cell responses induced by recombinant influenza and vaccinia viruses. Cell Immunol (1996) 1.38
Circumsporozoite gene of a Plasmodium falciparum strain from Thailand. Mol Biochem Parasitol (1987) 1.36
Immunization of monkeys against Plasmodium cynomolgi by X-irradiated sporozoites. Nat New Biol (1972) 1.36
Malaria in urban and rural areas of southern Ghana: a survey of parasitaemia, antibodies, and antimalarial practices. Bull World Health Organ (1984) 1.36
Erythrocyte membrane-associated immunoglobulins during malaria infection of mice. J Immunol (1977) 1.36
Immuno-electron microscopic observations on Plasmodium knowlesi sporozoites: localization of protective antigen and its precursors. Am J Trop Med Hyg (1984) 1.35
Studies on the persistence of malarial antibody response. Am J Epidemiol (1968) 1.35
Stage-specific antigens on the surface membrane of sporozoites of malaria parasites. Nature (1978) 1.33
Studies on the characterization of plasmodium vivax strains from Central America. Am J Trop Med Hyg (1972) 1.32